Alert: We're here for you. Learn how COVID-19 may affect your mesothelioma treatment and doctor appointments.

Dr. Jun Zhang

Dr. Jun Zhang

Thoracic Oncologist

Innovative thoracic medical oncologist Dr. Jun Zhang treats patients with lung cancer and pleural mesothelioma at Houston Methodist Hospital. Her research focuses on novel treatments and cancer immunotherapy.

Get in touch
Jump to a Topic:

About Jun Zhang

  • Board Certified icon

    Board Certified in Medical Oncology

  • Pleural and Lung Cancer icon

    Pleural and Lung Cancer

  • Research Excellence icon

    Excellence in Research

Get to Know Dr. Jun Zhang

Dr. Jun Zhang is a medical oncologist using innovative therapy to treat patients with lung cancer, pleural mesothelioma and head and neck cancers at Houston Methodist Hospital.

She utilizes her keen understanding of tumor biology and genomics, along with novel immunotherapy and standard of care treatment, to give her patients the best opportunity to fight cancer.

“With cancer care you can make a real difference in someone’s life,” she said. “I care about my patients like family. I usually tell them, ‘I can’t guarantee I can cure you, but I can guarantee you that I’ll always be there to make a difference.’”

Zhang served previously in the department of hematology-oncology at the Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine. She also has clinical expertise in kidney and bladder cancers.

Specialties of Dr. Jun Zhang

  • Mesothelioma

  • Lung cancer

  • Immunotherapy

  • Cancer genomics

  • Head and neck cancer

  • Kidney cancer

  • Bladder cancer

Dr. Jun Zhang’s Experience and Medical Education

  • Houston Methodist Hospital

  • Baylor College of Medicine

  • Brody School of Medicine, East Carolina University (Fellowship)

  • New Hanover Regional Medical Center, North Carolina (Residency)

  • Brookdale University Hospital Medical Center, New York (Residency)

  • Hunan Medical University, China (M.D.)

Awards and Other Recognitions

  • Board certification, internal medicine and medical oncology

  • CMS meaningful use stage 1, electronic health records

Mesothelioma Clinical Trials Under Dr. Jun Zhang

  • A phase III, randomized multicenter study of the immunotherapy drug durvalumab vs. placebo following stereotactic body radiation therapy for patients with unresectable tumors.

See More Top Mesothelioma Doctors

Publications of Dr. Jun Zhang

  • Swami, U., Zakharia, Y. & Zhang, J. (2018, October 4). Understanding Microbiome Effect on Immune Checkpoint Inhibition in Lung Cancer: Placing the Puzzle Pieces Together. Journal of Immunotherapy.

  • Strouse, C., Mangalam, A. & Zhang, J. (2018, September 5). Bugs in the System: Bringing the Human Microbiome to Bear in Cancer Immunotherapy. Gut Microbes.

  • Zhang, J. et al. (2016, August 19). Targeting DNA Replication Stress for Cancer Therapy. Genes.

  • Zhang, J. et al. (2015, July 7). Targeting HER (ERBB) Signaling in Head and Neck Cancer: An Essential Update. Molecular Aspects of Medicine.

Disclaimer: Dr. Jun Zhang has no professional affiliation with

stethoscope icon
Get Help Contacting this Doctor

We value your privacy. By submitting, you agree to our privacy policy and disclaimer. Mesothelioma Packet

Get a Free Treatment Guide Sent Overnight

Get Yours Now

Find Ways to Pay for Treatment Costs

Get Started

Find an Active Mesothelioma Clinical Trial

Find Now

Senior Content Writer

Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers.

Walter Pacheco, Managing Editor at
Edited by

1 Cited Article Sources

The sources on all content featured in The Mesothelioma Center at include medical and scientific studies, peer-reviewed studies and other research documents from reputable organizations.

  1. Houston Methodist. (n.d.). Jun Zhang, MD. Retrieved from:

Did this article help you?

Did this article help you?

Thank you for your feedback. Would you like to speak with a Patient Advocate?

Share this article

Last Modified August 9, 2020

Get Your Free Mesothelioma Guide Chat live with a patient advocate now